AI Science Tracker
EN

Department of Neurosurgery

3 discoveries from 2022 to 2025

Discoveries

Early Prediction of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage Using a Machine Learning Model and Interactive Web Application.

Source check: Source checked. Not independent scientific confirmation.

Finding: ML model predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage using clinical variables. Results compares predictions with angiographically confirmed vasospasm in a defined cohort; retrospective clinical validation.

Technology: ML model predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage using clinical variables.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ML model predicts cerebral vasospasm after aneurysmal subarachnoid hemorrhage using clinical variables.
Test and result
Results compares predictions with angiographically confirmed vasospasm in a defined cohort; retrospective clinical validation.
Limitation / still unknown
Validation basis and its limits are stated in Results.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/articles/PMC12650305?pdf=render · https://pubmed.ncbi.nlm.nih.gov/41300194/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature; the source analyzes TCGA LGG (475), then CGGA cohorts (170 and 420) for prognostic and clinicomolecular replication. Drug/immune response findings are computational response estimates, not demonstrated treatment benefit.

Technology: Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning screening selected CRNDE, LINC00665 and NEAT1 to form an EMT-related lncRNA signature.
Limitation / still unknown
Drug/immune response findings are computational response estimates, not demonstrated treatment benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2022.942966/full · https://pubmed.ncbi.nlm.nih.gov/36090045/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Sex differences in rTMS treatment response: A deep learning-based EEG investigation.

Source check: Source checked. Not independent scientific confirmation.

Finding: Deep-learning EEG classifiers distinguished pre/post-rTMS and response groups in a small MDD cohort; the paper explicitly cautions that classifier performance does not establish that one sex benefits more from treatment.

Technology: Methods describe 25 women and 25 men and five EEG classifiers; Results report >91% pre/post classification and a male-responder subgroup result, with class imbalance and explicit limits in the Discussion.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods describe 25 women and 25 men and five EEG classifiers; Results report >91% pre/post classification and a male-responder subgroup result, with class imbalance and explicit limits in the Discussion.
Test and result
Methods describe 25 women and 25 men and five EEG classifiers; Results report >91% pre/post classification and a male-responder subgroup result, with class imbalance and explicit limits in the Discussion.
Limitation / still unknown
Methods describe 25 women and 25 men and five EEG classifiers; Results report >91% pre/post classification and a male-responder subgroup result, with class imbalance and explicit limits in the Discussion.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9392544/ · https://pubmed.ncbi.nlm.nih.gov/35879921/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.